Norepinephrine Neurons

Norepinephrine Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Norepinephrine Neurons</th>
</tr>
<tr> [@reinikainen1988]
<td class="label">Lineage</td> [@ross2020]
<td>Neuron > Catecholaminergic > Noradrenergic</td> [@heneka2010]
</tr> [@chalermpalanupap2013]
<tr> [@zarow2003]
<td class="label">Markers</td>
<td>DBH, TH, PHOX2A, PHOX2B, SLC6A2A, SLC6A2B, ADRA2A</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Locus coeruleus, Subcoeruleus nucleus, Lateral tegmental nuclei</td>
</tr>
<tr>
<td class="label">Disease Vulnerability</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [FTD](/diseases/ftd), [Narcolepsy](/diseases/narcolepsy)</td>
</tr>
</table>

Norepinephrine Neurons

Introduction

Norepinephrine Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

...

Norepinephrine Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Norepinephrine Neurons</th>
</tr>
<tr> [@reinikainen1988]
<td class="label">Lineage</td> [@ross2020]
<td>Neuron > Catecholaminergic > Noradrenergic</td> [@heneka2010]
</tr> [@chalermpalanupap2013]
<tr> [@zarow2003]
<td class="label">Markers</td>
<td>DBH, TH, PHOX2A, PHOX2B, SLC6A2A, SLC6A2B, ADRA2A</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Locus coeruleus, Subcoeruleus nucleus, Lateral tegmental nuclei</td>
</tr>
<tr>
<td class="label">Disease Vulnerability</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [FTD](/diseases/ftd), [Narcolepsy](/diseases/narcolepsy)</td>
</tr>
</table>

Norepinephrine Neurons

Introduction

Norepinephrine Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Norepinephrine (NE) Neurons are catecholaminergic neurons that produce and release the neurotransmitter norepinephrine (noradrenaline).[@berridge2003] The majority of noradrenergic neurons in the mammalian brain are located in the locus coeruleus (LC), a compact nucleus in the dorsal pons.[@sara2009]

These neurons project widely throughout the central nervous system, innervating the cerebral cortex, hippocampus, thalamus, cerebellum, and spinal cord. This diffuse projection pattern allows norepinephrine to modulate overall brain state and arousal.[@astonjones2005]
<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:0000459](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000459) | noradrenergic cell |

External Database Links

• [Cell Ontology (CL:0000459)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000459)
• [OBO Foundry (CL:0000459)](http://purl.obolibrary.org/obo/CL_0000459)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Marker Genes

Noradrenergic neurons are identified by expression of:

• DBH - Dopamine beta-hydroxylase, converts dopamine to norepinephrine
• TH - Tyrosine hydroxylase, rate-limiting enzyme in catecholamine synthesis
• PHOX2A / PHOX2B - Transcription factors required for noradrenergic development
• SLC6A2A - Norepinephrine transporter (NET)
• SLC6A2B - Norepinephrine transporter variant
• ADRA2A - Alpha-2A adrenergic receptor (autoreceptor)

Normal Function

Norepinephrine neurons perform essential functions in brain physiology:

Neurotransmission

• Synthesize norepinephrine from dopamine via DBH
• Utilize vesicular monoamine transporter (VMAT2) for packaging
• Release norepinephrine as both neurotransmitter and neurohormone

Brain-Wide Modulation

• Provide diffuse projections to most brain regions
• Modulate neuronal excitability and synaptic plasticity
• Regulate the signal-to-noise ratio in target circuits

Behavioral Regulation

• Arousal and attention: LC activity correlates with wakefulness and vigilance
• Stress response: Central noradrenergic system mediates stress reactivity
• Memory consolidation: NE enhances memory consolidation, particularly for emotional memories
• Pain modulation: Descending NE pathways inhibit pain transmission in spinal cord

Role in Neurodegenerative Diseases

Alzheimer's Disease

Norepinephrine neurons show early vulnerability in AD:

• LC degeneration: One of the earliest and most severely affected regions in AD[@mann1980]
• Norepinephrine loss: Marked reduction in cortical NE levels in AD brain[@reinikainen1988]
• Cognitive decline[5]</a: Noradrenergic dysfunction contributes to attention and memory deficits[@ross2020]
• Neuroinflammation: NE has anti-inflammatory effects; its loss may exacerbate neuroinflammation[@heneka2010]
• Therapeutic potential: NE-enhancing drugs may have beneficial effects in AD[@chalermpalanupap2013]

Parkinson's Disease

• LC involvement: Noradrenergic neurons degenerate in PD[@zarow2003]
• Non-motor symptoms: NE loss contributes to depression, fatigue, and autonomic dysfunction
• Cognitive impairment: Noradrenergic dysfunction contributes to PD dementia
• Locus coeruleus pathology: LC degeneration precedes dopaminergic loss in some cases

Frontotemporal Dementia

• Noradrenergic neuron loss in FTD
• Contributes to neuropsychiatric symptoms
• Interactions with tau pathology

Narcolepsy

• Selective loss: NE neurons are affected in narcolepsy
• Wakefulness regulation: NE system dysfunction contributes to excessive daytime sleepiness
• Cataplexy: Noradrenergic modulation affects cataplexy episodes

Therapeutic Implications

Drug Targets

• Norepinephrine reuptake inhibitors (NRIs): Atomoxetine, reboxetine
• Alpha-2 agonists: Clonidine, guanfacine
• Beta-blockers: Propranolol (peripheral)
• SNRIs: Venlafaxine, duloxetine

Experimental Approaches

• LC stimulation: Deep brain stimulation of locus coeruleus
• NE prodrugs: L-threo-DOPS (droxidopa) to increase NE levels
• Cell therapy: Noradrenergic neuron transplantation
• Gene therapy: DBH gene delivery

See Also

• [Cell-Types/Norepinephrine-Neurons — This page

](/cell-types/cell-types-norepinephrine-neurons-—-this-page)## Background

The study of Norepinephrine Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

astonjones2005, Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance (2005)
berridge2003, The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes (2003)
chalermpalanupap2013, Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease (2013)
heneka2010, Locus coeruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine (2010)
mann1980, The locus coeruleus in Alzheimer's disease (1980)
reinikainen1988, Decreased noradrenaline concentration in Alzheimer's disease brain (1988)
ross2020, Locus coeruleus catecholamine depletion and memory deficits in people with cognitive impairment (2020)
sara2009, The locus coeruleus and noradrenergic modulation of cognition (2009)
zarow2003, Neuronal loss is greater than the loss of noradrenergic neurons in the locus coeruleus in Parkinson's disease (2003)

Pathway Diagram

The following diagram shows the key molecular relationships involving Norepinephrine Neurons discovered through SciDEX knowledge graph analysis: